ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43625
0.14%
Bitcoin
95,868.58
-1.38%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) News

Azitra Inc

Azitra Inc (AZTR)

AMEX
0.415
0.0198
(5.01%)
Closed December 22 3:00PM
Delayed by 15 minutes
0.39
-0.025
(-6.02%)
After Hours: 6:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

AZTR News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
November 26 2024
AZTR (5.01%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 12 2024
AZTR (5.01%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
October 09 2024
AZTR (5.01%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
October 09 2024
AZTR (5.01%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
September 16 2024
AZTR (5.01%)

AZTR Discussion

View Posts
Monksdream Monksdream 1 month ago
AZTR, new 52/low
👍️0
Monksdream Monksdream 2 months ago
AZTR new 52 week low
👍️0
herbied47 herbied47 3 months ago
AZTR 800k cash on hand from Q2 balance sheet and $10M from recent offering… after recent cash burn currently $9M cash on hand and currently trading at $4M market cap. BUY!
👍️0
herbied47 herbied47 3 months ago
Online surveys are more lucrative then this mess.
👍️0
herbied47 herbied47 3 months ago
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
👍️0
herbied47 herbied47 3 months ago
Should be getting an update soon. Strong buy right here with this kind of low float.
👍️0
Viewmont Viewmont 4 months ago
https://finance.yahoo.com/news/azitra-announces-first-patient-dosed-123000947.html
👍️ 1
Viewmont Viewmont 4 months ago
Moving after hours, what's up?
👍️0
herbied47 herbied47 4 months ago
Press releases left and right. Sabby closing their short position the other day was the first clue. This will trade not
north of $3.00 soon! Load up!
👍️0
glenn1919 glenn1919 4 months ago
AZTR................................https://stockcharts.com/h-sc/ui?s=AZTR&p=W&b=5&g=0&id=p86431144783
👍️0
mikey4 mikey4 4 months ago
Shoulda dumped, looked a gift horse in the mouth and said “no thanks.”
👍️0
herbied47 herbied47 4 months ago
Gap fill. Going back up! $1.50 open
👍️0
Invest-in-America Invest-in-America 4 months ago
AZTR; Be very careful --- merely PHASE-1, & a RARE skin disorder to boot. (Ain't goin' nowhere.)
👍️0
FROZENFLAME FROZENFLAME 4 months ago
Nice thanks
👍️0
mikey4 mikey4 4 months ago
Another dilution guaranteed

This is the easiest to estimate as the average duration for each phase is known. Roughly these are;

*Discovery - 3 years

*Pre-clinical - 1 year

*Phase I - 1/1.5 years

*Phase II - 1.5/2.5 years

*Phase III - 2/4 years

*Filing - 0.75 years

These are rough of course. In particular orphan drugs tend to progress faster as they can combine clinical phases.
👍️0
FROZENFLAME FROZENFLAME 4 months ago
Waiting on volume !
👍️0
FROZENFLAME FROZENFLAME 4 months ago
Just need some volume !
👍️0
mikey4 mikey4 4 months ago
In 11,000 @0.63 here. Is this even close to accurate?

Here are the revenue forecasts for Azitra, Inc. (AZTR) for the next 5 years ¹:
- *2024*: No forecast available
- *2025*: $3 million
- *2026*: $0
- *2027*: $0
- *2028*: $21 million
- *2029*: $93 million
- *2030*: $165 million
- *2031*: $229 million

Please note that these forecasts are subject to change and might not reflect the company's current financial situation.
👍️0
FROZENFLAME FROZENFLAME 4 months ago
I will love to see after-hours run, usually they are the best, patiently waiting !
👍️0
Viewmont Viewmont 4 months ago
Yes, let's!
👍️0
Viewmont Viewmont 4 months ago
https://finance.yahoo.com/news/azitra-inc-announces-q2-2024-222300234.html
👍️0
FROZENFLAME FROZENFLAME 4 months ago
Let’s have a nice squeeze $$$
👍️0
Viewmont Viewmont 4 months ago
It's moving up! Let's go!
👍️0
FROZENFLAME FROZENFLAME 4 months ago
Loaded and ready
👍️ 1
Viewmont Viewmont 4 months ago
Yup! it should start going back up! https://schrts.co/ZVhEAaat
👍️0
FROZENFLAME FROZENFLAME 4 months ago
I like this

Completed a follow-on offering of $10 million in gross proceeds expected to provide cash runway into 2025. With the recent financing, the company anticipates announcing multiple clinical milestones
Strengthened global intellectual property portfolio with newly granted and allowed patents
Exhibited positive preclinical data from ATR-04 at the Society of Investigative Dermatology Annual Meeting
Presented positive preclinical data of ATR-12 and clinical design in Netherton Syndrome at the ASGCT Annual Meeting
Opened a Phase 1b clinical trial for ATR-12 for recruitment
👍️ 1
Viewmont Viewmont 4 months ago
$AZTR https://www.otcmarkets.com/filing/html?id=17752131&guid=y8O-kq652gSvB3h
👍️0
Viewmont Viewmont 4 months ago
$AZTR Trying to move up! And there's a lot of room to do so! IMO.

BRANFORD, Conn., July 25, 2024--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions.

The updated release reads:

AZITRA, INC. ANNOUNCES CLOSING OF $10.0 MILLION PUBLIC OFFERING

Azitra, Inc. (NYSE American: AZTR) ("Company"), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the closing of its previously announced public offering of an aggregate of 6,665,000 shares of its common stock, and Class A warrants to purchase up to 13,330,000 shares of common stock, at a combined public offering price of $1.50 per share and accompanying warrants. The Class A warrant will have an initial exercise price of $1.50 per share, will be exercisable immediately upon issuance, and will expire on the fifth anniversary of the original issuance date.
👍️0
Viewmont Viewmont 4 months ago
$AZTR https://schrts.co/pStTnWQN
👍️0
FROZENFLAME FROZENFLAME 4 months ago
Pressure building up !
👍️0
FROZENFLAME FROZENFLAME 4 months ago
A run of this level will be epic !
👍️0
FROZENFLAME FROZENFLAME 4 months ago
Nice thanks
👍️0
FROZENFLAME FROZENFLAME 4 months ago
40s on the way !
👍️0
FROZENFLAME FROZENFLAME 5 months ago
Not looking good, looks like 50s on the way, CEO dead silent !
👍️0
PennyPusher786 PennyPusher786 5 months ago
Scam company. I'm 93 % down in only the past few months. Do not buy
👍️0
PennyPusher786 PennyPusher786 5 months ago
Don't buy it
👍️0
Monksdream Monksdream 5 months ago
AZTR new 52 week low
👍️0
herbied47 herbied47 5 months ago
https://ir.azitrainc.com/news-releases/news-release-details/azitra-inc-strengthens-global-intellectual-property-portfolio this was just days ago of which it hit $12 then. Shoot yes here!
👍️0
PennyPusher786 PennyPusher786 5 months ago
Up 11% from the bottom though. A averaging down would've been nice for a quick 10% profit lol...

These pricks just did a share offering though. I have my eyes on GNS CEOS BNED for a near term move
👍️0
PennyPusher786 PennyPusher786 5 months ago
Up 11% from the bottom though. A averaging down would've been nice for a quick 10% profit lol...

These pricks just did a share offering though. I have my eyes on GNS CEOS BNED for a near term move
👍️0
PennyPusher786 PennyPusher786 5 months ago
They're doing it to secure their pockets. God forbid they should actually earn money for once.

Fricken credit lines, and share offerings. And nieve shareholders to foot the bill... The west is finished lol...
👍️0
FROZENFLAME FROZENFLAME 5 months ago
Same everywhere, I’m not sure how that even can be legal, check $SIDU they been doing this for the last 2 years, crazy !
👍️0
FROZENFLAME FROZENFLAME 5 months ago
https://scr.zacks.com/news/news-details/2024/AZTR-Get-Some-Skin-in-the-Game-article/default.aspx
👍️0
PennyPusher786 PennyPusher786 5 months ago
I would consider a provEN OTC ticker at this point such that has room to grow like $CEOS

These nasdaq bioplays suck... pure reverse Splits and share offerings and barely ever a buyout or product that comes to fruition. Just CEOs and management using retail money to keep their income rolling
👍️0
PennyPusher786 PennyPusher786 5 months ago
These morons ran a reverse split to get the share price out of pennies, then a share offering after a run up to $12.... and immediately dumped it under $1 again.

May God curse the management with for stealing money from share holders and lining their pockets.

Disgusting
👍️0
FROZENFLAME FROZENFLAME 5 months ago
Loading the 52WL, gambling here lol .
👍️0
Monksdream Monksdream 5 months ago
AZTR new 52 week low
👍️0
FROZENFLAME FROZENFLAME 5 months ago
New lows everywhere !
👍️0
FROZENFLAME FROZENFLAME 5 months ago
New 52WL after hours .96 !
👍️0
FROZENFLAME FROZENFLAME 5 months ago
https://www.businesswire.com/news/home/20240725675771/en/
👍️0

Your Recent History

AMEX
AZTR
Azitra
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads